INTERSTITIAL LUNG DISEASE: RETROSPECTIVE STUDY OF THE PROGNOSTIC IMPACT OF ACUTE EXACERBATIONS

被引:0
|
作者
Pacheco, Joana M. [1 ]
Santos, Ana I. [1 ]
Catarata, Joana [2 ]
Freitas, Sara [1 ]
机构
[1] Coimbra Hosp & Univ Ctr, Pulmonol Dept, Mota Pinto,3004-56, Coimbra, Portugal
[2] Braga Hosp, Pulmonol Dept, Braga, Portugal
关键词
KEY WORDS: interstitial lung disease; pulmonary fibrosis; acute exacerbation;
D O I
10.36141/svdld.v41i4.15198
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Interstitial lung diseases have high mortality associated with hospitalization for decompensation. There are doubts about the factors involved in the progression of fibrosis, for example the role played by acute exacerbations. With this work, the authors intend to analyze whether there are predictive parameters of mortality related to exacerbations. Methods: A retrospective study was carried out of patients admitted to the Pulmonology department of Coimbra University Hospital Center for exacerbation of fibrosing lung disease between January 2019 and December 2020. These were classified as: idiopathic pulmonary fibrosis (IPF), fibrosing hypersensivity pneumonitis (FHP) and other fibrosing lung diseases. Statistical analysis was performed using SPSS 26.0 considering statistically significant p<0.05 values. Results: The results show that IPF is associated with longer hospital stay in relation to fibrosing HP and other fibrosing lung diseases mean of 20.93 days (95% CI: 14.69-27.18) vs 11.8 days (95% CI: 1.05-17.22, p=0.023) vs 12.23 days (95% CI: 2.06-15.34, p=0.007), respectively. Regarding mortality, there was no difference between IPF, PH and other fibrosing diseases (p=0.631). Conclusion: This study demonstrated that IPF, compared to PH and other fibrosing diseases, is associated with longer hospital stays, probably due to its progressive course despite the institution of corticosteroid therapy. As shown in previous studies, it was concluded that there is no difference in terms of mortality between IPF exacerbations and other forms of fibrosing lung disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Interstitial lung disease in a veterans affairs regional network; a retrospective cohort study
    Bedoya, Armando
    Pleasants, Roy A.
    Boggan, Joel C.
    Seaman, Danielle
    Reihman, Anne
    Howard, Lauren
    Kundich, Robert
    Welty-Wolf, Karen
    Tighe, Robert M.
    PLOS ONE, 2021, 16 (03):
  • [22] Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study
    Zhao, Jin
    Guo, Xiao-Jing
    Shi, Lei
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (01) : 113 - 122
  • [23] Steroid therapy in acute exacerbation of fibrotic interstitial lung disease
    Koshy, Kavya
    Barnes, Hayley
    Farrand, Erica
    Glaspole, Ian
    RESPIROLOGY, 2024, 29 (09) : 795 - 802
  • [24] Impact of palliative radiotherapy with or without lung irradiation in patients with interstitial lung disease
    Makita, Kenji
    Hamamoto, Yasushi
    Kanzaki, Hiromitsu
    Nagasaki, Kei
    Sugawara, Yoshifumi
    Kozuki, Toshiyuki
    RADIOTHERAPY AND ONCOLOGY, 2023, 183
  • [25] Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study
    Liang, Junyu
    Cao, Heng
    Ke, Yini
    Sun, Chuanyin
    Chen, Weiqian
    Lin, Jin
    FRONTIERS IN MEDICINE, 2020, 7
  • [26] Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease
    Kono, Masato
    Miyashita, Koichi
    Hirama, Ryutaro
    Oshima, Yuiko
    Takeda, Kenichiro
    Mochizuka, Yasutaka
    Tsutsumi, Akari
    Miwa, Hideki
    Miki, Yoshihiro
    Hashimoto, Dai
    Suda, Takafumi
    Nakamura, Hidenori
    RESPIRATORY MEDICINE, 2021, 186
  • [27] Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease A Nationwide Survey
    Koyauchi, Takafumi
    Fujisawa, Tomoyuki
    Miyashita, Mitsunori
    Mori, Masanori
    Morita, Tatsuya
    Yazawa, Shusuke
    Akiyama, Norimichi
    Hagimoto, Satoshi
    Matsuda, Yoshinobu
    Tachikawa, Ryo
    Yasui, Hideki
    Suzuki, Masaru
    Asai, Yuichiro
    Ono, Manabu
    Kimura, Yuichiro
    Ohkouchi, Shinya
    Tanino, Yoshinori
    Sugino, Keishi
    Tateishi, Tomoya
    Kato, Motoyasu
    Miyamoto, Atsushi
    Saito, Yoshinobu
    Sakamoto, Susumu
    Kono, Masato
    Yokomura, Koshi
    Imokawa, Shiro
    Sakamoto, Koji
    Waseda, Yuko
    Handa, Tomohiro
    Hattori, Noboru
    Anabuki, Kazuki
    Yatera, Kazuhiro
    Shundo, Yuki
    Hoshino, Tomoaki
    Sakamoto, Noriho
    Kondoh, Yasuhiro
    Tomioka, Hiromi
    Tomii, Keisuke
    Inoue, Yoshikazu
    Suda, Takafumi
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2025, 22 (03)
  • [28] Acute Exacerbation of Idiopathic Interstitial Pneumonia Following Lung Surgery in 3 of 68 Consecutive Patients: A Retrospective Study
    Sakamoto, Susumu
    Homma, Sakae
    Mun, Mingyon
    Fujii, Takeshi
    Kurosaki, Atsuko
    Yoshimura, Kunihiko
    INTERNAL MEDICINE, 2011, 50 (02) : 77 - 85
  • [29] Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study
    Arai, Toru
    Akira, Masanori
    Sugimoto, Chikatoshi
    Tachibana, Kazunobu
    Inoue, Yasushi
    Shintani, Sayoko
    Okuma, Tomohisa
    Kasai, Takahiko
    Hayashi, Seiji
    Inoue, Yoshikazu
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4132 - +
  • [30] Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
    Faverio, Paola
    Stainer, Anna
    Conti, Sara
    Madotto, Fabiana
    De Giacomi, Federica
    Della Zoppa, Matteo
    Vancheri, Ada
    Pellegrino, Maria Rosaria
    Tonelli, Roberto
    Cerri, Stefania
    Clini, Enrico M.
    Mantovani, Lorenzo Giovanni
    Pesci, Alberto
    Luppi, Fabrizio
    DIAGNOSTICS, 2021, 11 (09)